Concurrent FOLFIRINOX Plus High Intensity Focused Ultrasound for Pancreatic Cancer

Clinical trial NCT05262452 · UNKNOWN

Trial details

NCT number: NCT05262452
Sponsor: Seoul National University Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Pancreatic Cancer Non-resectable Chemotherapy Effect Ultrasound Therapy

Start date: 2021-08-09
Primary completion: 2023-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.